Logo
x

Search

Subscribe Now

~$2.49B

Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19

Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19

  • November 12, 2021
Coloplast to Acquire Atos Medical for ~$2.49B

Coloplast to Acquire Atos Medical for ~$2.49B

  • November 10, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.